Hege Elvebakken
4PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 14, 2025
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.Halfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark
|May 17, 2025
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.Halfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark
|Jun 22, 2024
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms.Hege Elvebakken, Andreas Venizelos, Aurel Perren
|Apr 05, 2023
Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms.Hege Elvebakken, Geir Olav Hjortland, Herish Garresori
Pageof 1
